Kanaly Trust’s Bristol-Myers Squibb BMY Stock Holding History

Kanaly Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$424K	Sell	7,258 -269	-4%	-$14.7K	0.09%	94
2016 Q3	$406K	Sell	7,527 -1,695	-18%	-$109K	0.09%	106
2016 Q2	$678K	Sell	9,222 -287	-3%	-$20.3K	0.14%	81
2016 Q1	$607K	Sell	9,509 -1,382	-13%	-$87.2K	0.12%	86
2015 Q4	$749K	Sell	10,891 -75	-0.7%	-$4.96K	0.15%	75
2015 Q3	$649K	Sell	10,966 -109	-1%	-$6.92K	0.14%	80
2015 Q2	$737K	Buy	11,075 +422	+4%	+$27.8K	0.15%	81
2015 Q1	$687K	Buy	10,653 +666	+7%	+$41.7K	0.13%	86
2014 Q4	$590K	Sell	9,987 -9,096	-48%	-$513K	0.12%	93
2014 Q3	$977K	Buy	19,083 +201	+1%	+$10K	0.19%	61
2014 Q2	$916K	Buy	18,882 +301	+2%	+$14.8K	0.17%	75
2014 Q1	$965K	Sell	18,581 -86	-0.5%	-$4.58K	0.19%	68
2013 Q4	$992K	Buy	18,667 +13,367	+252%	+$681K	0.2%	70
2013 Q3	$244K	Hold	5,300	–	–	0.07%	79
2013 Q2	$236K	Buy	+5,300	New	+$230K	0.07%	72

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Kanaly Trust's BMY Position: Q4 2016 in Review

Kanaly Trust reduced its Bristol-Myers Squibb (BMY) stake by 3.6% in Q4 2016, selling an estimated $14.7K and leaving 7,258 shares worth $424K. The position accounts for 0.09% of the portfolio, ranked #94.

Kanaly Trust first reported a position in BMY in Q2 2013 and has held it in 15 quarters since. The position peaked at $992K in Q4 2013. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Kanaly Trust held 7,258 shares of Bristol-Myers Squibb worth $424K as of Q4 2016.
Kanaly Trust sold 269 Bristol-Myers Squibb shares in Q4 2016, an estimated $14.7K.
Bristol-Myers Squibb made up 0.09% of Kanaly Trust's portfolio in Q4 2016, its #94 holding.
Kanaly Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 15 quarters since.
Kanaly Trust's Bristol-Myers Squibb position peaked at $992K in Q4 2013.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.